The global Epoetin (Eritropoyetin) market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Epoetin (Eritropoyetin) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Epoetin (Eritropoyetin) market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Epoetin (Eritropoyetin) in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Epoetin (Eritropoyetin) manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Amgen
Epoetin
Abcam
Johnson & Johnson
Hospira Inc
Roche
LG Life Sciences Ltd
Biocon
Intas Pharmaceuticals
Teva Pharmaceutical Industries Ltd
Ranbaxy Laboratories Ltd
Celltrion, Inc

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Epoetin-alfa
Epoetin-beta
Darbepoetin-alfa

Segment by Application
Anemia (Cancer and HIV treatment)
Kidney Disorders (ESRD and Dialysis)
Others (Neural Disease and Wound healing)